2024 AIChE Annual Meeting

Area: Pharmaceutical Discovery, Development and Manufacturing Forum

Chair

Michael Lovette, Eli Lilly

Sessions sponsored

Advancements in Drug Product Particle Engineering and Material Science
Sponsored by:
Co-sponsored by:
Advancements in Drug Substance Processing and Material Science
Sponsored by:
Co-sponsored by:
Advances in Control Strategy for Continuous Processes and Utilization of PATs
Sponsored by:
Advances in Control Strategy towards Drug Substance and Drug Product Unit Operations
Sponsored by:
Advances in Control Strategy using Modeling Tools and Approaches
Sponsored by:
Advances in Control Strategy: Applications to Biopharmaceuticals Applications
Sponsored by:
Advances in Drug Discovery Processes (including HTE): Advanced Technology Approaches to Maximize Public Health Impacts
Sponsored by:
Advances in Drug Discovery Processes (including HTE): Protein Engineering Approaches with Target Therapeutic Applications
Sponsored by:
Advances in New Modalities: New Modalities & Technologies
Sponsored by:
Advances in New Modalities: Separations & Formulation 
Sponsored by:
Computational solid state pharmaceutics
Sponsored by:
Continuous Process: Next Generation Advancements
Sponsored by:
Continuous Processing in Drug Product
Sponsored by:
Continuous Processing in Drug Substance
Sponsored by:
Data-driven approaches, and ML/AI for pharmaceutical applications
Sponsored by:
Division Plenary: Pharmaceutical Discovery Development and Manufacturing (Invited Talks)
Sponsored by:
Enabling Technologies Relevant to Drug Product
Sponsored by:
Enabling Technologies Relevant to Drug Substance
Sponsored by:
Invited Talks: In Honor of Prof. Robert Prud'homme
Sponsored by:
Invited talks: In Honor of Ramki’s 85th Birthday to commemorate his Contributions to Biopharmaceutical Industry
Sponsored by:
Invited Talks: Sustainability in the Pharmaceutical Industry
Sponsored by:
Pharma 4.0 (Advanced Controls, Process Automation, Data Analytics, etc.)
Sponsored by:
Poster Session: Pharmaceutical Discovery, Development, and Manufacturing
Sponsored by:
Co-sponsored by:
Predictive Scale-Up/Scale-Down for Biopharmaceuticals
Sponsored by:
Predictive Scale-Up/Scale-Down for Pharmaceuticals
Sponsored by:
Co-sponsored by:
Process models for drug substance, drug product, and biopharmaceuticals Part 1
Sponsored by:
Process models for drug substance, drug product, and biopharmaceuticals Part 2
Sponsored by:

Sessions co-sponsored

Cato T. Laurencin Regenerative Engineering Founder's Award Lecture
Sponsored by:
Co-sponsored by:
Continuous Crystallization Processes
Sponsored by:
Co-sponsored by:
Crystallization and Precipitation of Pharmaceutical and Biological Molecules I
Sponsored by:
Co-sponsored by:
Crystallization and Precipitation of Pharmaceutical and Biological Molecules II
Sponsored by:
Co-sponsored by:
Featured MPC Session: Chemical Engineering Reimagined: Bringing Sustainable Innovation to Market
Sponsored by:
Co-sponsored by:
Featured MPC Session: Chemical Engineering Reimagined: Engineering the Future of Food
Sponsored by:
Co-sponsored by:
Foreign Species and Crystallization: Impurity Rejection, Additives, Dopants, etc.
Sponsored by:
Co-sponsored by:
John M. Prausnitz AIChE Institute Lecture
Sponsored by:
Co-sponsored by:
Mixing Issues in Scale-Up and Scale-Down of Pharmaceutical & Biopharmaceutical Processes
Sponsored by:
Co-sponsored by:
Modeling and Control of Crystallization I
Sponsored by:
Co-sponsored by:
Modeling and Control of Crystallization II
Sponsored by:
Co-sponsored by:
PAT and Process Monitoring in Crystallization Development and Manufacturing
Sponsored by:
Co-sponsored by:
Purdue Center for Operations and Optimization in Process Systems
Sponsored by:
Co-sponsored by:
Solid Form Characterization and Development: Cocrystals, Salts, Solvates, Polymorphs, and Beyond
Sponsored by:
Co-sponsored by: